Lista de obras - Suneil Jain - Dominio Público Uruguay

A comparison between accelerated hypofractionation and stereotactic ablative radiotherapy (SABR) for early-stage non-small cell lung cancer (NSCLC): Results of a propensity score-matched analysis.

artículo científico publicado en 2016

A novel CBCT-based method for derivation of CTV-PTV margins for prostate and pelvic lymph nodes treated with stereotactic ablative radiotherapy.

artículo científico

Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement.

artículo científico publicado en 2016

Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement Summary.

artículo científico publicado en 2016

An evaluation of techniques for dose calculation on cone beam computed tomography

scientific article published on 26 February 2019

An overview of current practice in external beam radiation oncology with consideration to potential benefits and challenges for nanotechnology.

artículo científico publicado en 2017

Biological consequences of nanoscale energy deposition near irradiated heavy atom nanoparticles

artículo científico publicado en 2011

Cell type-dependent uptake, localization, and cytotoxicity of 1.9 nm gold nanoparticles.

artículo científico publicado en 2012

Cell-Specific Radiosensitization by Gold Nanoparticles at Megavoltage Radiation Energies ⬇️

artículo científico publicado el 20 de noviembre de 2010

Cellular signalling effects in high precision radiotherapy

artículo científico publicado en 2015

Class solutions for SABR-VMAT for high-risk prostate cancer with and without elective nodal irradiation.

artículo científico publicado en 2016

Computed Tomography-based Radiomics for Risk Stratification in Prostate Cancer

scientific article published on 26 June 2019

Conventional in vivo irradiation procedures are insufficient to accurately determine tumor responses to non-uniform radiation fields.

artículo científico publicado en 2014

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer ⬇️

artículo científico publicado en 2015

Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer.

artículo científico publicado en 2018

Efficacy of a rectal spacer with prostate SABR - first UK experience.

artículo científico publicado en 2017

Energy Dependence of Gold Nanoparticle Radiosensitization in Plasmid DNA

Evaluation of a Machine-Learning Algorithm for Treatment Planning in Prostate Low-Dose-Rate Brachytherapy.

artículo científico publicado en 2016

Fiducial marker guided prostate radiotherapy: a review

artículo científico publicado en 2016

Gleason Upgrading with Time in a Large Prostate Cancer Active Surveillance Cohort.

artículo científico publicado en 2015

Gold nanoparticle cellular uptake, toxicity and radiosensitisation in hypoxic conditions.

artículo científico publicado en 2014

Gold nanoparticles as novel agents for cancer therapy ⬇️

artículo científico publicado el 18 de octubre de 2011

Imaging and radiation effects of gold nanoparticles in tumour cells

artículo científico publicado en 2016

Investigating the potential impact of four-dimensional computed tomography (4DCT) on toxicity, outcomes and dose escalation for radical lung cancer radiotherapy.

artículo científico publicado en 2013

Lung stereotactic body radiation therapy (SBRT) delivered over 4 or 11 days: a comparison of acute toxicity and quality of life

artículo científico publicado en 2013

Management of Bartholin's gland carcinoma using high-dose-rate interstitial brachytherapy boost.

artículo científico publicado en 2013

Motion management for radical radiotherapy in non-small cell lung cancer.

artículo científico publicado en 2013

Nanodosimetric effects of gold nanoparticles in megavoltage radiation therapy

artículo científico publicado en 2011

Predictive factors for local control in primary and metastatic lung tumours after four to five fraction stereotactic ablative body radiotherapy: a single institution's comprehensive experience

artículo científico publicado en 2014

Predictors of Chest Wall Toxicity after Lung Stereotactic Ablative Radiotherapy

artículo científico publicado en 2015

Prostate cancer radiotherapy: potential applications of metal nanoparticles for imaging and therapy.

artículo científico

Prostate cancer treated with brachytherapy; an exploratory study of dose-dependent biomarkers and quality of life.

artículo científico publicado en 2017

Prostate stereotactic ablative body radiotherapy using a standard linear accelerator: toxicity, biochemical, and pathological outcomes

artículo científico publicado en 2013

Radiotherapy in the presence of contrast agents: a general figure of merit and its application to gold nanoparticles

artículo científico publicado en 2008

Reply to J.J. Tosoian et al.

artículo científico publicado en 2016

Sector analysis provides additional spatial information on the permanent prostate brachytherapy learning curve

artículo científico publicado en 2015

Stereotactic Ablative Radiation Therapy for Pulmonary Metastases: Histology, Dose, and Indication Matter.

artículo científico publicado en 2017

Stereotactic Body Radiation Therapy Boost for Intermediate-Risk Prostate Cancer: A Phase 1 Dose-Escalation Study

artículo científico publicado en 2019

TRUFU: Therapeutic radiographer undertaking follow up for prostate cancer patients

artículo científico publicado en 2018

The Tablet-Based, Engagement, Assessment, Support, and Sign-Posting (EASSi) Tool for Facilitating and Structuring Sexual Well-Being Conversations in Routine Prostate Cancer Care: Mixed-Methods Study

artículo científico publicado en 2020

The effect of radiation technique and bladder filling on the acute toxicity of pelvic radiotherapy for localized high risk prostate cancer

article

Tumour Lysis Syndrome after Splenic Irradiation in a Patient with JAK2 V617F Post-polycythaemia Vera Myelofibrosis

scientific article published on 07 August 2010

UK & Ireland Prostate Brachytherapy Practice Survey 2014-2016.

artículo científico publicado en 2018

UK Consensus on Normal Tissue Dose Constraints for Stereotactic Radiotherapy. ⬇️

artículo científico publicado en 2017

Validation of a Metastatic Assay using biopsies to improve risk stratification in patients with prostate cancer treated with radical radiation therapy.

artículo científico publicado en 2018

Lista de obras de Suneil Jain

A comparison between accelerated hypofractionation and stereotactic ablative radiotherapy (SABR) for early-stage non-small cell lung cancer (NSCLC): Results of a propensity score-matched analysis.

A novel CBCT-based method for derivation of CTV-PTV margins for prostate and pelvic lymph nodes treated with stereotactic ablative radiotherapy.

Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement.

Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement Summary.

An evaluation of techniques for dose calculation on cone beam computed tomography

An overview of current practice in external beam radiation oncology with consideration to potential benefits and challenges for nanotechnology.

Biological consequences of nanoscale energy deposition near irradiated heavy atom nanoparticles

Cell type-dependent uptake, localization, and cytotoxicity of 1.9 nm gold nanoparticles.

Cell-Specific Radiosensitization by Gold Nanoparticles at Megavoltage Radiation Energies ⬇️

Cellular signalling effects in high precision radiotherapy

Class solutions for SABR-VMAT for high-risk prostate cancer with and without elective nodal irradiation.

Computed Tomography-based Radiomics for Risk Stratification in Prostate Cancer

Conventional in vivo irradiation procedures are insufficient to accurately determine tumor responses to non-uniform radiation fields.

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer ⬇️

Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer.

Efficacy of a rectal spacer with prostate SABR - first UK experience.

Energy Dependence of Gold Nanoparticle Radiosensitization in Plasmid DNA

Evaluation of a Machine-Learning Algorithm for Treatment Planning in Prostate Low-Dose-Rate Brachytherapy.

Fiducial marker guided prostate radiotherapy: a review

Gleason Upgrading with Time in a Large Prostate Cancer Active Surveillance Cohort.

Gold nanoparticle cellular uptake, toxicity and radiosensitisation in hypoxic conditions.

Gold nanoparticles as novel agents for cancer therapy ⬇️

Imaging and radiation effects of gold nanoparticles in tumour cells

Investigating the potential impact of four-dimensional computed tomography (4DCT) on toxicity, outcomes and dose escalation for radical lung cancer radiotherapy.

Lung stereotactic body radiation therapy (SBRT) delivered over 4 or 11 days: a comparison of acute toxicity and quality of life

Management of Bartholin's gland carcinoma using high-dose-rate interstitial brachytherapy boost.

Motion management for radical radiotherapy in non-small cell lung cancer.

Nanodosimetric effects of gold nanoparticles in megavoltage radiation therapy

Predictive factors for local control in primary and metastatic lung tumours after four to five fraction stereotactic ablative body radiotherapy: a single institution's comprehensive experience

Predictors of Chest Wall Toxicity after Lung Stereotactic Ablative Radiotherapy

Prostate cancer radiotherapy: potential applications of metal nanoparticles for imaging and therapy.

Prostate cancer treated with brachytherapy; an exploratory study of dose-dependent biomarkers and quality of life.

Prostate stereotactic ablative body radiotherapy using a standard linear accelerator: toxicity, biochemical, and pathological outcomes

Radiotherapy in the presence of contrast agents: a general figure of merit and its application to gold nanoparticles

Reply to J.J. Tosoian et al.

Sector analysis provides additional spatial information on the permanent prostate brachytherapy learning curve

Stereotactic Ablative Radiation Therapy for Pulmonary Metastases: Histology, Dose, and Indication Matter.

Stereotactic Body Radiation Therapy Boost for Intermediate-Risk Prostate Cancer: A Phase 1 Dose-Escalation Study

TRUFU: Therapeutic radiographer undertaking follow up for prostate cancer patients

The Tablet-Based, Engagement, Assessment, Support, and Sign-Posting (EASSi) Tool for Facilitating and Structuring Sexual Well-Being Conversations in Routine Prostate Cancer Care: Mixed-Methods Study

The effect of radiation technique and bladder filling on the acute toxicity of pelvic radiotherapy for localized high risk prostate cancer

Tumour Lysis Syndrome after Splenic Irradiation in a Patient with JAK2 V617F Post-polycythaemia Vera Myelofibrosis

UK & Ireland Prostate Brachytherapy Practice Survey 2014-2016.

UK Consensus on Normal Tissue Dose Constraints for Stereotactic Radiotherapy. ⬇️

Validation of a Metastatic Assay using biopsies to improve risk stratification in patients with prostate cancer treated with radical radiation therapy.